NEWS
Mibelle acquires rights to produce Mirexus phytoglycogen products
Swiss cosmetic active ingredient maker Mibelle Biochemistry has completed an asset deal with Mirexus Biotechnologies, a Canadian company that makes plant-derived glycogen (phytoglycogen) for use in personal care products. The deal means Mibelle has acquired IP
rights to produce Mirexus products including PhytoSpherix, EnerZea, Adveen and Susttain. The Ontario company’s products are now
fully integrated in the Mibelle portfolio and are available for purchase immediately. Mibelle said the asset deal strengthens its
active ingredient portfolio and enhances its position as a developer and manufacturer of unique, high-quality active ingredients for the cosmetic and nutraceutical industry.
Vytrus Biotech wins in-cos Latam gold
Spanish cosmetic ingredient maker Vytrus Biotech has been awarded the Gold Best Ingredient Award at in-cosmetics Latin America for its Elaya Renova natural active. Elaya Renova is a 100% natural active made
with stem cells from the wild olive tree, an ancestral Mediterranean species. Vytrus Biotech says the active protects,
reinforces, regenerates, and beautifies the whole hair structure, from scalp to hair shaft with a plant strategy. “Specifically enriched in a nourishing
proteo-lipidic matrix, it reinforces both the hair and scalp from the inside, facing the challenge of a global hair care skinification,” it adds. Latest Vytrus’ innovation is inspired by the
architectural concept of ‘Tensegrity’. The Tensegrity explains how changes
applied to an area will also exert effects at a distance because everything is interconnected. Vytrus has transferred this vision of
tensegrity to the hair structure, launching the new cosmetic approach of TrichoTensegrity, appealing to the importance of the scalp and the hair structure and its influence on hair mechanical properties and biology behaviour.
The new assets also drive Mibelle
Biochemistry’s sustainable innovation efforts by further aligning the portfolio with the rising demand for natural and sustainable ingredients. “I am very excited about this asset deal, as
we had been looking around for quite a while to find a perfect target, matching our philosophy ‘Inspired by Nature – Realized by Science’ and similarly fitting smoothly into our existing product portfolio,“ said managing director Cornelia Schürch. “PhytoSpherix is finally fulfilling both requirements.” Phil Whiting, president and CEO of Mirexus
Biotechnologies, added: “The deep knowledge and capabilities of Mibelle will enable the growth of this technology beyond what Mirexus could do
on its own. “We look forward to seeing the continued
expansion of our technology under Mibelle’s experienced leadership.” Further financial terms relating to the transaction were not disclosed.
13
www.personalcaremagazine.com
November 2022 PERSONAL CARE
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92
